Co‑organized with GBAICTI and its key facility RWSAC, the 2026 GBA Real-world Research and Application Forum brought together representatives from government, regulatory authorities, academia, and industry across overseas, the Chinese Mainland and GBA, including Hong Kong.
The “Learning from Neighbours” forum successfully resumed after Covid, focusing on the theme “Fostering an Eco-system for Medical and Pharmaceutical Advancement.”
To help members understand the latest policy, the HKAPI Regulatory Affairs Working Group held a workshop on July 10, 2025, focusing on the CMPR's strategic plan and the "1+" mechanism.
On June 13, the HKAPI CDCC & CDF Project Team successfully hosted a Primary Healthcare Workshop in collaboration with the Roles of Community Pharmacy Project Team. Nearly 50 members joined us for this engaging event, and we are grateful for your participation.
We are pleased to inform members about a successful online sharing session hosted by the HKAPI PSP Archetype for Hong Kong & DPMS Project Team on April 16th.
We are excited to share that approximately 120 members joined the recent seminar on Value-Based Medicine, hosted by HKAPI's catalyst member, Vista Health. The seminar focused on "Best Practices in Real-World Data: Perspectives from Outside of Hong Kong," providing valuable insights into the application of real-world evidence (RWE) in healthcare decision-making.
On February 25, the HKAPI Chronic Disease Co-Care Scheme (CDCC) & Community Drug Formulary (CDF) Project Team hosted an online sharing session with over 100 members participating.
On 29 November 2024, HKAPI jointly organized with Business Ethics Development Centre (BEDC) of Independent Commission Against Corruption (ICAC) and Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA) to hold a seminar on “Integrity Management Seminar for Executives of the Medical and Healthcare Industry”.